Medical Research News

RSS

Artery scans detect “silent atherosclerosis” in 1 in 13 adults under 30

Researchers studying 16,808 adults aged 18 to 70 found that silent atherosclerosis was detectable in early adulthood, with plaque present in 57.1% of those who completed imaging across three arterial territories. Plaque prevalence and burden were higher in older age groups, with men showing earlier evidence of disease than women, while conventional cardiovascular risk scores identified relatively few people with existing plaque.

10 Nov 2026

Video-assisted informed consent shortens face-to-face cancer surgery consultations

For patients undergoing gastric cancer surgery, informed consent (IC) can involve extensive information about surgical methods, complications, risks, benefits, and life after treatment.

10 Nov 2026

Targeting brain cleaning gene could help treat or prevent Alzheimer's

A gene responsible for compacting trash inside the brain appears to be a key player in Alzheimer's disease, and doctors may be able to target it to better treat or help prevent the devastating condition, new UVA Health research suggests.

10 Nov 2026

Mayo Clinic research advances treatment options for genitourinary cancers

Cancers of the reproductive and urinary organs, known as genitourinary cancers, affect millions of people worldwide each year. Yousef Zakharia, M.D., a Mayo Clinic medical oncologist, leads clinical research aimed at improving treatment results for patients with kidney, bladder and prostate cancers.

10 Nov 2026

Protein marker detects early Huntington's disease before brain damage

Before motor or cognitive impairments appear and before brain volume loss becomes evident, some individuals carrying the genetic mutation that causes Huntington's disease already show signs of neuronal injury.

10 Nov 2026

Subtle changes in deep sleep before Alzheimer's symptoms appear

The study identifies slow-wave sleep alterations as potential biomarkers for Alzheimer's, emphasizing their role in cognitive health and disease progression.

10 Nov 2026

Regular coffee consumption alters gut bacteria and digestive physiology

If you drink coffee regularly, it appears to alter not only your gut bacteria but also the physiology of the gut itself. That is the conclusion of a study from the University of Copenhagen, which may help point the way towards better treatments for constipation.

10 Nov 2026

Common blood pressure drugs may improve ulcerative colitis therapy

A class of blood pressure medications may improve a widely used treatment for ulcerative colitis, the most common type of inflammatory bowel disease, suggests a new study, led by Northwestern Medicine and Kiel University in Germany, of thousands of patients with the disease.

10 Nov 2026

Meeting WHO's air pollution guidelines could save nine million lives

Meeting the World Health Organization's recommended annual guidelines for air pollution resulting from fine particulate matter and nitrogen dioxide has the potential to save more than 9 million lives a year in low- and middle-income countries, say University of Cambridge researchers.

10 Nov 2026

Tobacco use independently linked to anorectal sensorimotor dysfunction and fecal incontinence

Tobacco use is independently associated with anorectal sensorimotor dysfunction and fecal incontinence, according to a recent study published ahead of print in The American Journal of Gastroenterology.

10 Nov 2026

A weight-loss drug eased knee arthritis pain in two major trials

Retatrutide effectively alleviates knee pain and enhances mobility in obese osteoarthritis patients, but long-term safety and joint health remain uncertain.

10 Nov 2026

Could a common diabetes drug help prevent long COVID?

Metformin use soon after COVID-19 infection is associated with a 53% reduction in long COVID or death risk, reinforcing previous clinical findings.

10 Nov 2026

Could Ozempic and Wegovy affect unborn babies?

They’re the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted pounds.

10 Nov 2026

Lab Thread launches new AI tools and strengthens platform with universal AI assistant compatibility

Lab Thread Ltd, a UK-based life science software company, today announced the launch of a new Model Context Protocol (MCP) server that lets scientists connect their own AI assistants directly to their laboratory data.

From Lab Thread 10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

European commission approves label expansion of Pepaxti to third-line treatment

Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, today announced that the European Commission (EC) has formally approved the Type II variation application for Pepaxti (melflufen).

From Oncopeptides AB (publ) 10 Nov 2026

Your Instagram photos may reveal more about loneliness than you think

Researchers analyzing Instagram data from 415 US college students found that photographs, language, and online activity provided moderately useful indicators of subjective loneliness but were less informative about social isolation. Social loneliness was associated with lower interpersonal engagement, while emotional loneliness was linked to negative language, sad or angry facial expressions in profile photographs, and late-night posting.

9 Nov 2026

Drinking 2–3 cups of coffee a day? A study of 495,000 adults links it to lower AF risk

In a prospective study of 495,269 UK Biobank participants followed for approximately 13 years, researchers found that coffee consumption was associated with a 7% to 11% lower risk of atrial fibrillation (AF), with the strongest association observed at 2–3 cups daily. Tea consumption showed a more modest and less consistent association, with the authors reporting a 5% lower AF risk at 2–3 cups daily, although the observational findings cannot establish causation.

9 Nov 2026

A child's sex may change how early sugar intake relates to body fat

A longitudinal study of 130 mother-child pairs found that added sugar intake during pregnancy was more strongly associated with body fat in girls, whereas exposure during infancy was more strongly associated with adiposity in boys at age two. The findings, based largely on a smaller group of 42 children with usable body-composition scans, are preliminary and do not establish a causal relationship.

9 Nov 2026

Late night eating and sleep habits damage gut health, increase metabolic disease risk

A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health, and metabolic disease, offering new insights into why some individuals with obesity may face risk of inflammation and related health problems.

9 Nov 2026